We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current VGLS market cap is 2.11M. The company's latest EPS is USD -0.0001 and P/E is 0.00.
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | 0 | 0 | -1.16M | -24k | -20k |
Net Income | -268k | -268k | -1.24M | -58k | -2.53M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 7.72M | 8.03M | 5.01M | 4.62M | 4.87M |
Total Equity | -7.72M | -8.03M | -5.01M | -4.62M | -4.87M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | N/A | N/A | N/A | -24k | -20k |
Investing | N/A | N/A | N/A | N/A | N/A |
Financing | N/A | N/A | N/A | 24k | 20k |
Market Cap | 2.11M |
Price to Earnings Ratio | 0.00 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 0 |
Dividend Yield | - |
Shares Outstanding | 21.1B |
Average Volume (1 week) | 8.22M |
Average Volume (1 Month) | 9.71M |
52 Week Change | 9,900.00% |
52 Week High | 0.0001 |
52 Week Low | 0.000001 |
Spread (Intraday) | 0 (0%) |
Company Name | VG Life Sciences Inc (PK) |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.vglscorp.com/ |
Industry | pharmaceutical diversified (H2) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions